IO Biotech/$IOBT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About IO Biotech
IO Biotech Inc is a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on T-win technology platform. The product candidates are designed to induce the immune system to simultaneously target and disrupt multiple pathways that regulate tumor-induced immunosuppression.
Ticker
$IOBT
Sector
Trading on
Industry
Biotechnology
Headquarters
Copenhagen, Denmark
Employees
79
ISIN
US4497781090
Website
IO Biotech Metrics
BasicAdvanced
$105M
-
-$1.49
0.09
-
Price and volume
Market cap
$105M
Beta
0.09
52-week high
$1.73
52-week low
$0.66
Average daily volume
165K
Financial strength
Current ratio
2.316
Quick ratio
2.079
Long term debt to equity
3.891
Total debt to equity
6.672
Management effectiveness
Return on assets (TTM)
-70.13%
Return on equity (TTM)
-138.78%
Valuation
Price to book
3.99
Price to tangible book (TTM)
3.99
Price to free cash flow (TTM)
-1.309
Growth
Earnings per share change (TTM)
-10.83%
3-year earnings per share growth (CAGR)
-41.68%
What the Analysts think about IO Biotech
Analyst ratings (Buy, Hold, Sell) for IO Biotech stock.
IO Biotech Financial Performance
Revenues and expenses
IO Biotech Earnings Performance
Company profitability
IO Biotech News
AllArticlesVideos
IO Biotech Announces Participation in Cowen 6th Annual Oncology Innovation Summit and Jefferies Global Healthcare Conference
GlobeNewsWire·3 weeks ago
IO Biotech Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewsWire·4 weeks ago
IO Biotech Showcases Scientific Leadership Through Cancer Vaccines Educational Session at the American Association for Cancer Research (AACR) Annual Meeting 2025
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for IO Biotech stock?
IO Biotech (IOBT) has a market cap of $105M as of June 09, 2025.
What is the P/E ratio for IO Biotech stock?
The price to earnings (P/E) ratio for IO Biotech (IOBT) stock is 0 as of June 09, 2025.
Does IO Biotech stock pay dividends?
No, IO Biotech (IOBT) stock does not pay dividends to its shareholders as of June 09, 2025.
When is the next IO Biotech dividend payment date?
IO Biotech (IOBT) stock does not pay dividends to its shareholders.
What is the beta indicator for IO Biotech?
IO Biotech (IOBT) has a beta rating of 0.09. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.